1. Home
  2. KOSS vs VNRX Comparison

KOSS vs VNRX Comparison

Compare KOSS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • VNRX
  • Stock Information
  • Founded
  • KOSS 1953
  • VNRX N/A
  • Country
  • KOSS United States
  • VNRX United States
  • Employees
  • KOSS N/A
  • VNRX N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • KOSS Consumer Staples
  • VNRX Health Care
  • Exchange
  • KOSS Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • KOSS 63.8M
  • VNRX 67.2M
  • IPO Year
  • KOSS N/A
  • VNRX N/A
  • Fundamental
  • Price
  • KOSS $6.95
  • VNRX $0.68
  • Analyst Decision
  • KOSS
  • VNRX Strong Buy
  • Analyst Count
  • KOSS 0
  • VNRX 4
  • Target Price
  • KOSS N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • KOSS 165.8K
  • VNRX 135.1K
  • Earning Date
  • KOSS 10-31-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • KOSS N/A
  • VNRX N/A
  • EPS Growth
  • KOSS N/A
  • VNRX N/A
  • EPS
  • KOSS N/A
  • VNRX N/A
  • Revenue
  • KOSS $12,092,999.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • KOSS N/A
  • VNRX $180.66
  • Revenue Next Year
  • KOSS N/A
  • VNRX $558.69
  • P/E Ratio
  • KOSS N/A
  • VNRX N/A
  • Revenue Growth
  • KOSS N/A
  • VNRX 97.50
  • 52 Week Low
  • KOSS $2.27
  • VNRX $0.43
  • 52 Week High
  • KOSS $18.73
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 45.52
  • VNRX 50.19
  • Support Level
  • KOSS $6.68
  • VNRX $0.55
  • Resistance Level
  • KOSS $7.77
  • VNRX $0.80
  • Average True Range (ATR)
  • KOSS 0.38
  • VNRX 0.07
  • MACD
  • KOSS -0.01
  • VNRX 0.01
  • Stochastic Oscillator
  • KOSS 24.77
  • VNRX 52.00

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: